Medical Care
Global Nutrigenomics Market Outlook, In‑Depth Analysis & Forecast to 2031
- Nov 04, 25
- ID: 569561
- Pages: 120
- Figures: 128
- Views: 5
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Nutrigenomics market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Interleukin Genetics
DNA Life
The Gene Box
Xcode Life
Cura Integrative Medicine
Metagenics
GX Sciences
Nutrigenomix
Genova Diagnostics
Holistic Health
Segment by Type
Reagents & Kits
Services
Segment by Application
Hospital
Online
Other
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the Nutrigenomics study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Nutrigenomics market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Interleukin Genetics
DNA Life
The Gene Box
Xcode Life
Cura Integrative Medicine
Metagenics
GX Sciences
Nutrigenomix
Genova Diagnostics
Holistic Health
Segment by Type
Reagents & Kits
Services
Segment by Application
Hospital
Online
Other
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the Nutrigenomics study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to Nutrigenomics: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Nutrigenomics Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Reagents & Kits
1.2.3 Services
1.3 Market Segmentation by Application
1.3.1 Global Nutrigenomics Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Online
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Nutrigenomics Revenue Estimates and Forecasts 2020-2031
2.2 Global Nutrigenomics Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Nutrigenomics Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Nutrigenomics Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Reagents & Kits Market Size by Players
3.3.2 Services Market Size by Players
3.4 Global Nutrigenomics Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Nutrigenomics Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Nutrigenomics Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Nutrigenomics Market Size by Type (2020-2031)
6.4 North America Nutrigenomics Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Nutrigenomics Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Nutrigenomics Market Size by Type (2020-2031)
7.4 Europe Nutrigenomics Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Nutrigenomics Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Nutrigenomics Market Size by Type (2020-2031)
8.4 Asia-Pacific Nutrigenomics Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Nutrigenomics Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Nutrigenomics Market Size by Type (2020-2031)
9.4 Central and South America Nutrigenomics Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Nutrigenomics Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Nutrigenomics Market Size by Type (2020-2031)
10.4 Middle East and Africa Nutrigenomics Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Nutrigenomics Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Interleukin Genetics
11.1.1 Interleukin Genetics Corporation Information
11.1.2 Interleukin Genetics Business Overview
11.1.3 Interleukin Genetics Nutrigenomics Product Features and Attributes
11.1.4 Interleukin Genetics Nutrigenomics Revenue and Gross Margin (2020-2025)
11.1.5 Interleukin Genetics Nutrigenomics Revenue by Product in 2024
11.1.6 Interleukin Genetics Nutrigenomics Revenue by Application in 2024
11.1.7 Interleukin Genetics Nutrigenomics Revenue by Geographic Area in 2024
11.1.8 Interleukin Genetics Nutrigenomics SWOT Analysis
11.1.9 Interleukin Genetics Recent Developments
11.2 DNA Life
11.2.1 DNA Life Corporation Information
11.2.2 DNA Life Business Overview
11.2.3 DNA Life Nutrigenomics Product Features and Attributes
11.2.4 DNA Life Nutrigenomics Revenue and Gross Margin (2020-2025)
11.2.5 DNA Life Nutrigenomics Revenue by Product in 2024
11.2.6 DNA Life Nutrigenomics Revenue by Application in 2024
11.2.7 DNA Life Nutrigenomics Revenue by Geographic Area in 2024
11.2.8 DNA Life Nutrigenomics SWOT Analysis
11.2.9 DNA Life Recent Developments
11.3 The Gene Box
11.3.1 The Gene Box Corporation Information
11.3.2 The Gene Box Business Overview
11.3.3 The Gene Box Nutrigenomics Product Features and Attributes
11.3.4 The Gene Box Nutrigenomics Revenue and Gross Margin (2020-2025)
11.3.5 The Gene Box Nutrigenomics Revenue by Product in 2024
11.3.6 The Gene Box Nutrigenomics Revenue by Application in 2024
11.3.7 The Gene Box Nutrigenomics Revenue by Geographic Area in 2024
11.3.8 The Gene Box Nutrigenomics SWOT Analysis
11.3.9 The Gene Box Recent Developments
11.4 Xcode Life
11.4.1 Xcode Life Corporation Information
11.4.2 Xcode Life Business Overview
11.4.3 Xcode Life Nutrigenomics Product Features and Attributes
11.4.4 Xcode Life Nutrigenomics Revenue and Gross Margin (2020-2025)
11.4.5 Xcode Life Nutrigenomics Revenue by Product in 2024
11.4.6 Xcode Life Nutrigenomics Revenue by Application in 2024
11.4.7 Xcode Life Nutrigenomics Revenue by Geographic Area in 2024
11.4.8 Xcode Life Nutrigenomics SWOT Analysis
11.4.9 Xcode Life Recent Developments
11.5 Cura Integrative Medicine
11.5.1 Cura Integrative Medicine Corporation Information
11.5.2 Cura Integrative Medicine Business Overview
11.5.3 Cura Integrative Medicine Nutrigenomics Product Features and Attributes
11.5.4 Cura Integrative Medicine Nutrigenomics Revenue and Gross Margin (2020-2025)
11.5.5 Cura Integrative Medicine Nutrigenomics Revenue by Product in 2024
11.5.6 Cura Integrative Medicine Nutrigenomics Revenue by Application in 2024
11.5.7 Cura Integrative Medicine Nutrigenomics Revenue by Geographic Area in 2024
11.5.8 Cura Integrative Medicine Nutrigenomics SWOT Analysis
11.5.9 Cura Integrative Medicine Recent Developments
11.6 Metagenics
11.6.1 Metagenics Corporation Information
11.6.2 Metagenics Business Overview
11.6.3 Metagenics Nutrigenomics Product Features and Attributes
11.6.4 Metagenics Nutrigenomics Revenue and Gross Margin (2020-2025)
11.6.5 Metagenics Recent Developments
11.7 GX Sciences
11.7.1 GX Sciences Corporation Information
11.7.2 GX Sciences Business Overview
11.7.3 GX Sciences Nutrigenomics Product Features and Attributes
11.7.4 GX Sciences Nutrigenomics Revenue and Gross Margin (2020-2025)
11.7.5 GX Sciences Recent Developments
11.8 Nutrigenomix
11.8.1 Nutrigenomix Corporation Information
11.8.2 Nutrigenomix Business Overview
11.8.3 Nutrigenomix Nutrigenomics Product Features and Attributes
11.8.4 Nutrigenomix Nutrigenomics Revenue and Gross Margin (2020-2025)
11.8.5 Nutrigenomix Recent Developments
11.9 Genova Diagnostics
11.9.1 Genova Diagnostics Corporation Information
11.9.2 Genova Diagnostics Business Overview
11.9.3 Genova Diagnostics Nutrigenomics Product Features and Attributes
11.9.4 Genova Diagnostics Nutrigenomics Revenue and Gross Margin (2020-2025)
11.9.5 Genova Diagnostics Recent Developments
11.10 Holistic Health
11.10.1 Holistic Health Corporation Information
11.10.2 Holistic Health Business Overview
11.10.3 Holistic Health Nutrigenomics Product Features and Attributes
11.10.4 Holistic Health Nutrigenomics Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
12 NutrigenomicsIndustry Chain Analysis
12.1 Nutrigenomics Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Nutrigenomics Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Nutrigenomics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
1.1 Introduction to Nutrigenomics: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Nutrigenomics Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Reagents & Kits
1.2.3 Services
1.3 Market Segmentation by Application
1.3.1 Global Nutrigenomics Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Online
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Nutrigenomics Revenue Estimates and Forecasts 2020-2031
2.2 Global Nutrigenomics Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Nutrigenomics Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Nutrigenomics Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Reagents & Kits Market Size by Players
3.3.2 Services Market Size by Players
3.4 Global Nutrigenomics Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Nutrigenomics Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Nutrigenomics Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Nutrigenomics Market Size by Type (2020-2031)
6.4 North America Nutrigenomics Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Nutrigenomics Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Nutrigenomics Market Size by Type (2020-2031)
7.4 Europe Nutrigenomics Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Nutrigenomics Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Nutrigenomics Market Size by Type (2020-2031)
8.4 Asia-Pacific Nutrigenomics Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Nutrigenomics Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Nutrigenomics Market Size by Type (2020-2031)
9.4 Central and South America Nutrigenomics Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Nutrigenomics Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Nutrigenomics Market Size by Type (2020-2031)
10.4 Middle East and Africa Nutrigenomics Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Nutrigenomics Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Interleukin Genetics
11.1.1 Interleukin Genetics Corporation Information
11.1.2 Interleukin Genetics Business Overview
11.1.3 Interleukin Genetics Nutrigenomics Product Features and Attributes
11.1.4 Interleukin Genetics Nutrigenomics Revenue and Gross Margin (2020-2025)
11.1.5 Interleukin Genetics Nutrigenomics Revenue by Product in 2024
11.1.6 Interleukin Genetics Nutrigenomics Revenue by Application in 2024
11.1.7 Interleukin Genetics Nutrigenomics Revenue by Geographic Area in 2024
11.1.8 Interleukin Genetics Nutrigenomics SWOT Analysis
11.1.9 Interleukin Genetics Recent Developments
11.2 DNA Life
11.2.1 DNA Life Corporation Information
11.2.2 DNA Life Business Overview
11.2.3 DNA Life Nutrigenomics Product Features and Attributes
11.2.4 DNA Life Nutrigenomics Revenue and Gross Margin (2020-2025)
11.2.5 DNA Life Nutrigenomics Revenue by Product in 2024
11.2.6 DNA Life Nutrigenomics Revenue by Application in 2024
11.2.7 DNA Life Nutrigenomics Revenue by Geographic Area in 2024
11.2.8 DNA Life Nutrigenomics SWOT Analysis
11.2.9 DNA Life Recent Developments
11.3 The Gene Box
11.3.1 The Gene Box Corporation Information
11.3.2 The Gene Box Business Overview
11.3.3 The Gene Box Nutrigenomics Product Features and Attributes
11.3.4 The Gene Box Nutrigenomics Revenue and Gross Margin (2020-2025)
11.3.5 The Gene Box Nutrigenomics Revenue by Product in 2024
11.3.6 The Gene Box Nutrigenomics Revenue by Application in 2024
11.3.7 The Gene Box Nutrigenomics Revenue by Geographic Area in 2024
11.3.8 The Gene Box Nutrigenomics SWOT Analysis
11.3.9 The Gene Box Recent Developments
11.4 Xcode Life
11.4.1 Xcode Life Corporation Information
11.4.2 Xcode Life Business Overview
11.4.3 Xcode Life Nutrigenomics Product Features and Attributes
11.4.4 Xcode Life Nutrigenomics Revenue and Gross Margin (2020-2025)
11.4.5 Xcode Life Nutrigenomics Revenue by Product in 2024
11.4.6 Xcode Life Nutrigenomics Revenue by Application in 2024
11.4.7 Xcode Life Nutrigenomics Revenue by Geographic Area in 2024
11.4.8 Xcode Life Nutrigenomics SWOT Analysis
11.4.9 Xcode Life Recent Developments
11.5 Cura Integrative Medicine
11.5.1 Cura Integrative Medicine Corporation Information
11.5.2 Cura Integrative Medicine Business Overview
11.5.3 Cura Integrative Medicine Nutrigenomics Product Features and Attributes
11.5.4 Cura Integrative Medicine Nutrigenomics Revenue and Gross Margin (2020-2025)
11.5.5 Cura Integrative Medicine Nutrigenomics Revenue by Product in 2024
11.5.6 Cura Integrative Medicine Nutrigenomics Revenue by Application in 2024
11.5.7 Cura Integrative Medicine Nutrigenomics Revenue by Geographic Area in 2024
11.5.8 Cura Integrative Medicine Nutrigenomics SWOT Analysis
11.5.9 Cura Integrative Medicine Recent Developments
11.6 Metagenics
11.6.1 Metagenics Corporation Information
11.6.2 Metagenics Business Overview
11.6.3 Metagenics Nutrigenomics Product Features and Attributes
11.6.4 Metagenics Nutrigenomics Revenue and Gross Margin (2020-2025)
11.6.5 Metagenics Recent Developments
11.7 GX Sciences
11.7.1 GX Sciences Corporation Information
11.7.2 GX Sciences Business Overview
11.7.3 GX Sciences Nutrigenomics Product Features and Attributes
11.7.4 GX Sciences Nutrigenomics Revenue and Gross Margin (2020-2025)
11.7.5 GX Sciences Recent Developments
11.8 Nutrigenomix
11.8.1 Nutrigenomix Corporation Information
11.8.2 Nutrigenomix Business Overview
11.8.3 Nutrigenomix Nutrigenomics Product Features and Attributes
11.8.4 Nutrigenomix Nutrigenomics Revenue and Gross Margin (2020-2025)
11.8.5 Nutrigenomix Recent Developments
11.9 Genova Diagnostics
11.9.1 Genova Diagnostics Corporation Information
11.9.2 Genova Diagnostics Business Overview
11.9.3 Genova Diagnostics Nutrigenomics Product Features and Attributes
11.9.4 Genova Diagnostics Nutrigenomics Revenue and Gross Margin (2020-2025)
11.9.5 Genova Diagnostics Recent Developments
11.10 Holistic Health
11.10.1 Holistic Health Corporation Information
11.10.2 Holistic Health Business Overview
11.10.3 Holistic Health Nutrigenomics Product Features and Attributes
11.10.4 Holistic Health Nutrigenomics Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
12 NutrigenomicsIndustry Chain Analysis
12.1 Nutrigenomics Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Nutrigenomics Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Nutrigenomics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Nutrigenomics Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Nutrigenomics Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Nutrigenomics Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Nutrigenomics Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Nutrigenomics Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Nutrigenomics Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Nutrigenomics Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Nutrigenomics by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nutrigenomics as of 2024)
Table 11. Global Nutrigenomics Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Nutrigenomics Companies Headquarters
Table 13. Global Nutrigenomics Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Nutrigenomics Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Nutrigenomics Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Nutrigenomics Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Nutrigenomics Revenue by Application (2026-2031) & (US$ Million)
Table 21. Nutrigenomics High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Nutrigenomics Growth Accelerators and Market Barriers
Table 25. North America Nutrigenomics Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Nutrigenomics Growth Accelerators and Market Barriers
Table 27. Europe Nutrigenomics Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Nutrigenomics Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Nutrigenomics Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Nutrigenomics Investment Opportunities and Key Challenges
Table 31. Central and South America Nutrigenomics Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Nutrigenomics Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Nutrigenomics Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Interleukin Genetics Corporation Information
Table 35. Interleukin Genetics Description and Major Businesses
Table 36. Interleukin Genetics Product Features and Attributes
Table 37. Interleukin Genetics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Interleukin Genetics Revenue Proportion by Product in 2024
Table 39. Interleukin Genetics Revenue Proportion by Application in 2024
Table 40. Interleukin Genetics Revenue Proportion by Geographic Area in 2024
Table 41. Interleukin Genetics Nutrigenomics SWOT Analysis
Table 42. Interleukin Genetics Recent Developments
Table 43. DNA Life Corporation Information
Table 44. DNA Life Description and Major Businesses
Table 45. DNA Life Product Features and Attributes
Table 46. DNA Life Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. DNA Life Revenue Proportion by Product in 2024
Table 48. DNA Life Revenue Proportion by Application in 2024
Table 49. DNA Life Revenue Proportion by Geographic Area in 2024
Table 50. DNA Life Nutrigenomics SWOT Analysis
Table 51. DNA Life Recent Developments
Table 52. The Gene Box Corporation Information
Table 53. The Gene Box Description and Major Businesses
Table 54. The Gene Box Product Features and Attributes
Table 55. The Gene Box Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. The Gene Box Revenue Proportion by Product in 2024
Table 57. The Gene Box Revenue Proportion by Application in 2024
Table 58. The Gene Box Revenue Proportion by Geographic Area in 2024
Table 59. The Gene Box Nutrigenomics SWOT Analysis
Table 60. The Gene Box Recent Developments
Table 61. Xcode Life Corporation Information
Table 62. Xcode Life Description and Major Businesses
Table 63. Xcode Life Product Features and Attributes
Table 64. Xcode Life Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Xcode Life Revenue Proportion by Product in 2024
Table 66. Xcode Life Revenue Proportion by Application in 2024
Table 67. Xcode Life Revenue Proportion by Geographic Area in 2024
Table 68. Xcode Life Nutrigenomics SWOT Analysis
Table 69. Xcode Life Recent Developments
Table 70. Cura Integrative Medicine Corporation Information
Table 71. Cura Integrative Medicine Description and Major Businesses
Table 72. Cura Integrative Medicine Product Features and Attributes
Table 73. Cura Integrative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Cura Integrative Medicine Revenue Proportion by Product in 2024
Table 75. Cura Integrative Medicine Revenue Proportion by Application in 2024
Table 76. Cura Integrative Medicine Revenue Proportion by Geographic Area in 2024
Table 77. Cura Integrative Medicine Nutrigenomics SWOT Analysis
Table 78. Cura Integrative Medicine Recent Developments
Table 79. Metagenics Corporation Information
Table 80. Metagenics Description and Major Businesses
Table 81. Metagenics Product Features and Attributes
Table 82. Metagenics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Metagenics Recent Developments
Table 84. GX Sciences Corporation Information
Table 85. GX Sciences Description and Major Businesses
Table 86. GX Sciences Product Features and Attributes
Table 87. GX Sciences Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. GX Sciences Recent Developments
Table 89. Nutrigenomix Corporation Information
Table 90. Nutrigenomix Description and Major Businesses
Table 91. Nutrigenomix Product Features and Attributes
Table 92. Nutrigenomix Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Nutrigenomix Recent Developments
Table 94. Genova Diagnostics Corporation Information
Table 95. Genova Diagnostics Description and Major Businesses
Table 96. Genova Diagnostics Product Features and Attributes
Table 97. Genova Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Genova Diagnostics Recent Developments
Table 99. Holistic Health Corporation Information
Table 100. Holistic Health Description and Major Businesses
Table 101. Holistic Health Product Features and Attributes
Table 102. Holistic Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Holistic Health Recent Developments
Table 104. Raw Materials Key Suppliers
Table 105. Distributors List
Table 106. Market Trends and Market Evolution
Table 107. Market Drivers and Opportunities
Table 108. Market Challenges, Risks, and Restraints
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Nutrigenomics Product Picture
Figure 2. Global Nutrigenomics Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Reagents & Kits Product Picture
Figure 4. Services Product Picture
Figure 5. Global Nutrigenomics Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Hospital
Figure 7. Online
Figure 8. Other
Figure 9. Nutrigenomics Report Years Considered
Figure 10. Global Nutrigenomics Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Nutrigenomics Revenue (2020-2031) & (US$ Million)
Figure 12. Global Nutrigenomics Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Nutrigenomics Revenue Market Share by Region (2020-2031)
Figure 14. Global Nutrigenomics Revenue Market Share Ranking (2024)
Figure 15. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 16. Reagents & Kits Revenue Market Share by Player in 2024
Figure 17. Services Revenue Market Share by Player in 2024
Figure 18. Global Nutrigenomics Revenue Market Share by Type (2020-2031)
Figure 19. Global Nutrigenomics Revenue Market Share by Application (2020-2031)
Figure 20. North America Nutrigenomics Revenue YoY (2020-2031) & (US$ Million)
Figure 21. North America Top 5 Players Nutrigenomics Revenue (US$ Million) in 2024
Figure 22. North America Nutrigenomics Revenue (US$ Million) by Type (2020 - 2031)
Figure 23. North America Nutrigenomics Revenue (US$ Million) by Application (2020-2031)
Figure 24. US Nutrigenomics Revenue (2020-2031) & (US$ Million)
Figure 25. Canada Nutrigenomics Revenue (2020-2031) & (US$ Million)
Figure 26. Mexico Nutrigenomics Revenue (2020-2031) & (US$ Million)
Figure 27. Europe Nutrigenomics Revenue YoY (2020-2031) & (US$ Million)
Figure 28. Europe Top 5 Players Nutrigenomics Revenue (US$ Million) in 2024
Figure 29. Europe Nutrigenomics Revenue (US$ Million) by Type (2020-2031)
Figure 30. Europe Nutrigenomics Revenue (US$ Million) by Application (2020-2031)
Figure 31. Germany Nutrigenomics Revenue (2020-2031) & (US$ Million)
Figure 32. France Nutrigenomics Revenue (2020-2031) & (US$ Million)
Figure 33. U.K. Nutrigenomics Revenue (2020-2031) & (US$ Million)
Figure 34. Italy Nutrigenomics Revenue (2020-2031) & (US$ Million)
Figure 35. Russia Nutrigenomics Revenue (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Nutrigenomics Revenue YoY (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Top 8 Players Nutrigenomics Revenue (US$ Million) in 2024
Figure 38. Asia-Pacific Nutrigenomics Revenue (US$ Million) by Type (2020-2031)
Figure 39. Asia-Pacific Nutrigenomics Revenue (US$ Million) by Application (2020-2031)
Figure 40. Indonesia Nutrigenomics Revenue (2020-2031) & (US$ Million)
Figure 41. Japan Nutrigenomics Revenue (2020-2031) & (US$ Million)
Figure 42. South Korea Nutrigenomics Revenue (2020-2031) & (US$ Million)
Figure 43. Australia Nutrigenomics Revenue (2020-2031) & (US$ Million)
Figure 44. India Nutrigenomics Revenue (2020-2031) & (US$ Million)
Figure 45. Indonesia Nutrigenomics Revenue (2020-2031) & (US$ Million)
Figure 46. Vietnam Nutrigenomics Revenue (2020-2031) & (US$ Million)
Figure 47. Malaysia Nutrigenomics Revenue (2020-2031) & (US$ Million)
Figure 48. Philippines Nutrigenomics Revenue (2020-2031) & (US$ Million)
Figure 49. Singapore Nutrigenomics Revenue (2020-2031) & (US$ Million)
Figure 50. Central and South America Nutrigenomics Revenue YoY (2020-2031) & (US$ Million)
Figure 51. Central and South America Top 5 Players Nutrigenomics Revenue (US$ Million) in 2024
Figure 52. Central and South America Nutrigenomics Revenue (US$ Million) by Type (2020-2031)
Figure 53. Central and South America Nutrigenomics Revenue (US$ Million) by Application (2020-2031)
Figure 54. Brazil Nutrigenomics Revenue (2020-2025) & (US$ Million)
Figure 55. Argentina Nutrigenomics Revenue (2020-2025) & (US$ Million)
Figure 56. Middle East and Africa Nutrigenomics Revenue YoY (2020-2031) & (US$ Million)
Figure 57. Middle East and Africa Top 5 Players Nutrigenomics Revenue (US$ Million) in 2024
Figure 58. South America Nutrigenomics Revenue (US$ Million) by Type (2020-2031)
Figure 59. Middle East and Africa Nutrigenomics Revenue (US$ Million) by Application (2020-2031)
Figure 60. GCC Countries Nutrigenomics Revenue (2020-2025) & (US$ Million)
Figure 61. Israel Nutrigenomics Revenue (2020-2025) & (US$ Million)
Figure 62. Egypt Nutrigenomics Revenue (2020-2025) & (US$ Million)
Figure 63. South Africa Nutrigenomics Revenue (2020-2025) & (US$ Million)
Figure 64. Nutrigenomics Industry Chain Mapping
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Table 1. Global Nutrigenomics Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Nutrigenomics Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Nutrigenomics Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Nutrigenomics Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Nutrigenomics Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Nutrigenomics Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Nutrigenomics Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Nutrigenomics by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nutrigenomics as of 2024)
Table 11. Global Nutrigenomics Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Nutrigenomics Companies Headquarters
Table 13. Global Nutrigenomics Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Nutrigenomics Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Nutrigenomics Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Nutrigenomics Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Nutrigenomics Revenue by Application (2026-2031) & (US$ Million)
Table 21. Nutrigenomics High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Nutrigenomics Growth Accelerators and Market Barriers
Table 25. North America Nutrigenomics Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Nutrigenomics Growth Accelerators and Market Barriers
Table 27. Europe Nutrigenomics Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Nutrigenomics Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Nutrigenomics Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Nutrigenomics Investment Opportunities and Key Challenges
Table 31. Central and South America Nutrigenomics Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Nutrigenomics Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Nutrigenomics Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Interleukin Genetics Corporation Information
Table 35. Interleukin Genetics Description and Major Businesses
Table 36. Interleukin Genetics Product Features and Attributes
Table 37. Interleukin Genetics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Interleukin Genetics Revenue Proportion by Product in 2024
Table 39. Interleukin Genetics Revenue Proportion by Application in 2024
Table 40. Interleukin Genetics Revenue Proportion by Geographic Area in 2024
Table 41. Interleukin Genetics Nutrigenomics SWOT Analysis
Table 42. Interleukin Genetics Recent Developments
Table 43. DNA Life Corporation Information
Table 44. DNA Life Description and Major Businesses
Table 45. DNA Life Product Features and Attributes
Table 46. DNA Life Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. DNA Life Revenue Proportion by Product in 2024
Table 48. DNA Life Revenue Proportion by Application in 2024
Table 49. DNA Life Revenue Proportion by Geographic Area in 2024
Table 50. DNA Life Nutrigenomics SWOT Analysis
Table 51. DNA Life Recent Developments
Table 52. The Gene Box Corporation Information
Table 53. The Gene Box Description and Major Businesses
Table 54. The Gene Box Product Features and Attributes
Table 55. The Gene Box Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. The Gene Box Revenue Proportion by Product in 2024
Table 57. The Gene Box Revenue Proportion by Application in 2024
Table 58. The Gene Box Revenue Proportion by Geographic Area in 2024
Table 59. The Gene Box Nutrigenomics SWOT Analysis
Table 60. The Gene Box Recent Developments
Table 61. Xcode Life Corporation Information
Table 62. Xcode Life Description and Major Businesses
Table 63. Xcode Life Product Features and Attributes
Table 64. Xcode Life Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Xcode Life Revenue Proportion by Product in 2024
Table 66. Xcode Life Revenue Proportion by Application in 2024
Table 67. Xcode Life Revenue Proportion by Geographic Area in 2024
Table 68. Xcode Life Nutrigenomics SWOT Analysis
Table 69. Xcode Life Recent Developments
Table 70. Cura Integrative Medicine Corporation Information
Table 71. Cura Integrative Medicine Description and Major Businesses
Table 72. Cura Integrative Medicine Product Features and Attributes
Table 73. Cura Integrative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Cura Integrative Medicine Revenue Proportion by Product in 2024
Table 75. Cura Integrative Medicine Revenue Proportion by Application in 2024
Table 76. Cura Integrative Medicine Revenue Proportion by Geographic Area in 2024
Table 77. Cura Integrative Medicine Nutrigenomics SWOT Analysis
Table 78. Cura Integrative Medicine Recent Developments
Table 79. Metagenics Corporation Information
Table 80. Metagenics Description and Major Businesses
Table 81. Metagenics Product Features and Attributes
Table 82. Metagenics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Metagenics Recent Developments
Table 84. GX Sciences Corporation Information
Table 85. GX Sciences Description and Major Businesses
Table 86. GX Sciences Product Features and Attributes
Table 87. GX Sciences Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. GX Sciences Recent Developments
Table 89. Nutrigenomix Corporation Information
Table 90. Nutrigenomix Description and Major Businesses
Table 91. Nutrigenomix Product Features and Attributes
Table 92. Nutrigenomix Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Nutrigenomix Recent Developments
Table 94. Genova Diagnostics Corporation Information
Table 95. Genova Diagnostics Description and Major Businesses
Table 96. Genova Diagnostics Product Features and Attributes
Table 97. Genova Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Genova Diagnostics Recent Developments
Table 99. Holistic Health Corporation Information
Table 100. Holistic Health Description and Major Businesses
Table 101. Holistic Health Product Features and Attributes
Table 102. Holistic Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Holistic Health Recent Developments
Table 104. Raw Materials Key Suppliers
Table 105. Distributors List
Table 106. Market Trends and Market Evolution
Table 107. Market Drivers and Opportunities
Table 108. Market Challenges, Risks, and Restraints
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Nutrigenomics Product Picture
Figure 2. Global Nutrigenomics Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Reagents & Kits Product Picture
Figure 4. Services Product Picture
Figure 5. Global Nutrigenomics Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Hospital
Figure 7. Online
Figure 8. Other
Figure 9. Nutrigenomics Report Years Considered
Figure 10. Global Nutrigenomics Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Nutrigenomics Revenue (2020-2031) & (US$ Million)
Figure 12. Global Nutrigenomics Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Nutrigenomics Revenue Market Share by Region (2020-2031)
Figure 14. Global Nutrigenomics Revenue Market Share Ranking (2024)
Figure 15. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 16. Reagents & Kits Revenue Market Share by Player in 2024
Figure 17. Services Revenue Market Share by Player in 2024
Figure 18. Global Nutrigenomics Revenue Market Share by Type (2020-2031)
Figure 19. Global Nutrigenomics Revenue Market Share by Application (2020-2031)
Figure 20. North America Nutrigenomics Revenue YoY (2020-2031) & (US$ Million)
Figure 21. North America Top 5 Players Nutrigenomics Revenue (US$ Million) in 2024
Figure 22. North America Nutrigenomics Revenue (US$ Million) by Type (2020 - 2031)
Figure 23. North America Nutrigenomics Revenue (US$ Million) by Application (2020-2031)
Figure 24. US Nutrigenomics Revenue (2020-2031) & (US$ Million)
Figure 25. Canada Nutrigenomics Revenue (2020-2031) & (US$ Million)
Figure 26. Mexico Nutrigenomics Revenue (2020-2031) & (US$ Million)
Figure 27. Europe Nutrigenomics Revenue YoY (2020-2031) & (US$ Million)
Figure 28. Europe Top 5 Players Nutrigenomics Revenue (US$ Million) in 2024
Figure 29. Europe Nutrigenomics Revenue (US$ Million) by Type (2020-2031)
Figure 30. Europe Nutrigenomics Revenue (US$ Million) by Application (2020-2031)
Figure 31. Germany Nutrigenomics Revenue (2020-2031) & (US$ Million)
Figure 32. France Nutrigenomics Revenue (2020-2031) & (US$ Million)
Figure 33. U.K. Nutrigenomics Revenue (2020-2031) & (US$ Million)
Figure 34. Italy Nutrigenomics Revenue (2020-2031) & (US$ Million)
Figure 35. Russia Nutrigenomics Revenue (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Nutrigenomics Revenue YoY (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Top 8 Players Nutrigenomics Revenue (US$ Million) in 2024
Figure 38. Asia-Pacific Nutrigenomics Revenue (US$ Million) by Type (2020-2031)
Figure 39. Asia-Pacific Nutrigenomics Revenue (US$ Million) by Application (2020-2031)
Figure 40. Indonesia Nutrigenomics Revenue (2020-2031) & (US$ Million)
Figure 41. Japan Nutrigenomics Revenue (2020-2031) & (US$ Million)
Figure 42. South Korea Nutrigenomics Revenue (2020-2031) & (US$ Million)
Figure 43. Australia Nutrigenomics Revenue (2020-2031) & (US$ Million)
Figure 44. India Nutrigenomics Revenue (2020-2031) & (US$ Million)
Figure 45. Indonesia Nutrigenomics Revenue (2020-2031) & (US$ Million)
Figure 46. Vietnam Nutrigenomics Revenue (2020-2031) & (US$ Million)
Figure 47. Malaysia Nutrigenomics Revenue (2020-2031) & (US$ Million)
Figure 48. Philippines Nutrigenomics Revenue (2020-2031) & (US$ Million)
Figure 49. Singapore Nutrigenomics Revenue (2020-2031) & (US$ Million)
Figure 50. Central and South America Nutrigenomics Revenue YoY (2020-2031) & (US$ Million)
Figure 51. Central and South America Top 5 Players Nutrigenomics Revenue (US$ Million) in 2024
Figure 52. Central and South America Nutrigenomics Revenue (US$ Million) by Type (2020-2031)
Figure 53. Central and South America Nutrigenomics Revenue (US$ Million) by Application (2020-2031)
Figure 54. Brazil Nutrigenomics Revenue (2020-2025) & (US$ Million)
Figure 55. Argentina Nutrigenomics Revenue (2020-2025) & (US$ Million)
Figure 56. Middle East and Africa Nutrigenomics Revenue YoY (2020-2031) & (US$ Million)
Figure 57. Middle East and Africa Top 5 Players Nutrigenomics Revenue (US$ Million) in 2024
Figure 58. South America Nutrigenomics Revenue (US$ Million) by Type (2020-2031)
Figure 59. Middle East and Africa Nutrigenomics Revenue (US$ Million) by Application (2020-2031)
Figure 60. GCC Countries Nutrigenomics Revenue (2020-2025) & (US$ Million)
Figure 61. Israel Nutrigenomics Revenue (2020-2025) & (US$ Million)
Figure 62. Egypt Nutrigenomics Revenue (2020-2025) & (US$ Million)
Figure 63. South Africa Nutrigenomics Revenue (2020-2025) & (US$ Million)
Figure 64. Nutrigenomics Industry Chain Mapping
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global UV Delayed Curing Adhesives Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Die-Casting Die Steel Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Adaptive Neuromodulation Therapy Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232